main page

These are most unique to you, but don't yet have a magnitude assigned
(hide)
Frequency: 0.0%
References:1
Frequency: 0.0%
References:4
Frequency: 0.0%
References:0
Frequency: 0.0%
References:3
Frequency: 0.0%
References:1
Frequency: 0.0%
References:2
Frequency: 0.0%
References:0
Frequency: 0.0%
References:1
Frequency: 0.0%
References:2
Frequency: 0.0%
References:4
Frequency: 0.0%
References:3
Frequency: 0.0%
References:1
Frequency: 0.0%
References:3
Frequency: 0.0%
References:0
rare
Frequency: 0.0%
References:1
Frequency: 0.0%
References:1
Frequency: 0.0%
References:7
Frequency: 0.0%
References:5
normal
Frequency: 0.0%
References:0
Frequency: 0.0%
References:1
Frequency: 0.0%
References:6
Frequency: 0.0%
References:0
[haplogroup:P]
Frequency: 0.0%
References:10
risk genotype for several disorders
Frequency: 0.9%
References:1
Frequency: 0.9%
References:2
Frequency: 0.9%
References:1
Frequency: 0.9%
References:0
Frequency: 0.9%
References:0
Frequency: 0.9%
References:3
Frequency: 0.9%
References:1
Frequency: 0.9%
References:1
Frequency: 0.9%
References:1
Frequency: 0.9%
References:1
Frequency: 0.9%
References:1
Frequency: 0.9%
References:10
Frequency: 0.9%
References:1
Frequency: 0.9%
References:11
Frequency: 0.9%
References:4
Frequency: 0.9%
References:9
Frequency: 0.9%
References:1
Frequency: 0.9%
References:6
Frequency: 0.9%
References:1
Frequency: 0.9%
References:3
Frequency: 0.9%
References:1
Frequency: 1.5%
References:1
Frequency: 1.7%
References:3
Frequency: 1.8%
References:1
Frequency: 1.8%
References:3
Frequency: 1.8%
References:1
Frequency: 1.8%
References:1
Frequency: 1.8%
References:4
Frequency: 1.8%
References:2
Frequency: 1.8%
References:1
Frequency: 1.8%
References:1
Frequency: 1.8%
References:1
Frequency: 1.8%
References:8
Frequency: 1.8%
References:3
Frequency: 1.8%
References:5
Frequency: 1.8%
References:1
Frequency: 1.8%
References:3
Frequency: 1.8%
References:1
Frequency: 1.8%
References:2
Frequency: 1.8%
References:1
Frequency: 1.8%
References:1
Frequency: 1.8%
References:1
Frequency: 1.8%
References:2
Frequency: 1.8%
References:10
Frequency: 1.8%
References:1
Frequency: 1.8%
References:2
Frequency: 1.8%
References:1
Frequency: 1.8%
References:1
Frequency: 1.8%
References:0
Frequency: 1.8%
References:2
Frequency: 2.7%
References:1
Frequency: 2.7%
References:1
Frequency: 2.7%
References:1
Frequency: 2.7%
References:1
Frequency: 2.7%
References:1
Frequency: 2.7%
References:5
Frequency: 2.7%
References:18
possibly increased risk of stroke 1.6x increased risk for stroke in an initial study, but failed to replicate in a followup.
Frequency: 2.7%
References:1
Frequency: 2.7%
References:1
Frequency: 2.7%
References:3
Frequency: 2.7%
References:2
Frequency: 2.7%
References:1
Frequency: 2.7%
References:2
Frequency: 2.7%
References:1
Frequency: 2.7%
References:6
Frequency: 2.7%
References:3
Frequency: 2.7%
References:1
Frequency: 2.7%
References:1
Frequency: 2.7%
References:1
Frequency: 2.7%
References:1
Frequency: 2.7%
References:1
Frequency: 2.7%
References:1
Frequency: 2.7%
References:4
Frequency: 2.7%
References:1
Frequency: 2.7%
References:1
Frequency: 2.7%
References:1
Frequency: 2.7%
References:4
Frequency: 2.7%
References:7
Frequency: 2.8%
References:7
Frequency: 3.1%
References:0
Frequency: 3.2%
References:1
Frequency: 3.3%
References:2
Recessive genotype uncertain pathogenicity A study of four consanguineous Pakistani families found that recessive cone-rod dystrophy (CRD) segregated with this SNP, which results in a Alanine to Serine missense mutation at the amino acid level in the RPGRIP1 protein. CRD manifests as an initial loss of colour vision (cone mediated functions) and of visual acuity, usually from the first or second decade of life, is followed by night blindness (largely rod mediated) and loss of peripheral visual fields. CRD patients also demonstrate severe photophobia. However, a second study studying mutations in several genes associated with visual disorders found the SNP has the same frequency in both case and control populations, indicating that this was not the causal mutation in the disease in the Pak...
Frequency: 3.5%
References:1
Frequency: 3.5%
References:1
Frequency: 3.5%
References:1
Frequency: 3.5%
References:27
0.80x reduced risk for glioblastoma
Frequency: 3.5%
References:1
Frequency: 3.5%
References:9
Frequency: 3.5%
References:1
Frequency: 3.5%
References:6
Frequency: 3.5%
References:0
Frequency: 3.5%
References:1
Frequency: 3.5%
References:0
Frequency: 3.5%
References:1
Frequency: 3.5%
References:2
Frequency: 3.5%
References:2
Frequency: 3.5%
References:1
Frequency: 3.5%
References:2
Frequency: 3.5%
References:2
Frequency: 3.5%
References:1
Frequency: 3.5%
References:1
Frequency: 3.5%
References:1
Frequency: 3.5%
References:1
Frequency: 3.5%
References:1
Frequency: 3.5%
References:2
Frequency: 3.5%
References:1
Frequency: 3.5%
References:1
Frequency: 3.5%
References:6
Frequency: 3.5%
References:1
Frequency: 3.5%
References:1
Frequency: 3.5%
References:1
Frequency: 3.5%
References:14
Frequency: 3.5%
References:6
Frequency: 3.5%
References:1
Frequency: 3.6%
References:3
Frequency: 3.6%
References:1
Frequency: 3.6%
References:2
Frequency: 3.6%
References:1
Frequency: 3.6%
References:3
Frequency: 3.6%
References:1
Frequency: 3.6%
References:11
Frequency: 4.4%
References:1
Frequency: 4.4%
References:1
Frequency: 4.4%
References:4
Frequency: 4.4%
References:3
Frequency: 4.4%
References:2
Frequency: 4.4%
References:0
Frequency: 4.4%
References:1
Frequency: 4.4%
References:1
Frequency: 4.4%
References:1
Frequency: 4.4%
References:1
Frequency: 4.4%
References:1
Frequency: 4.4%
References:2
Frequency: 4.4%
References:1
Frequency: 4.4%
References:1
Frequency: 4.4%
References:2
Frequency: 4.4%
References:1
Frequency: 4.4%
References:2
Frequency: 4.4%
References:1
Frequency: 4.4%
References:1
Frequency: 4.4%
References:1
Frequency: 4.4%
References:1
Frequency: 4.4%
References:2
Frequency: 4.5%
References:3
Frequency: 4.5%
References:1
Frequency: 4.5%
References:7
Frequency: 4.5%
References:1
Frequency: 4.5%
References:1
Frequency: 4.6%
References:0
Frequency: 4.6%
References:0
Frequency: 5.3%
References:1
Frequency: 5.3%
References:1
Frequency: 5.3%
References:1
Frequency: 5.3%
References:4
Frequency: 5.3%
References:2
Frequency: 5.3%
References:2
Frequency: 5.3%
References:1
Frequency: 5.3%
References:2
Frequency: 5.3%
References:1
Frequency: 5.3%
References:2
Frequency: 5.3%
References:2
Frequency: 5.3%
References:8
Frequency: 5.3%
References:8
lowest IgE levels
Frequency: 5.3%
References:1
Frequency: 5.3%
References:1
Frequency: 5.3%
References:1
Frequency: 5.3%
References:1
Frequency: 5.3%
References:1
Frequency: 5.3%
References:0
Frequency: 5.3%
References:1
Frequency: 5.3%
References:6
Frequency: 5.3%
References:1
Frequency: 5.3%
References:1
Frequency: 5.3%
References:1
Frequency: 5.4%
References:1
Frequency: 5.4%
References:1
Frequency: 5.4%
References:2
Frequency: 5.4%
References:1
Frequency: 5.4%
References:3
Frequency: 5.4%
References:1
Frequency: 5.4%
References:1
Frequency: 5.5%
References:1
Frequency: 6.2%
References:0
Frequency: 6.2%
References:1
Frequency: 6.2%
References:1
Frequency: 6.2%
References:4
Frequency: 6.2%
References:1
Frequency: 6.2%
References:1
Frequency: 6.2%
References:2
Frequency: 6.2%
References:1
Frequency: 6.2%
References:2
Frequency: 6.2%
References:0
Frequency: 6.2%
References:0
Frequency: 6.2%
References:1
Frequency: 6.2%
References:1
Frequency: 6.2%
References:2
Frequency: 6.2%
References:4
Frequency: 6.2%
References:2
Frequency: 6.2%
References:1
Frequency: 6.2%
References:2
Frequency: 6.2%
References:0
Frequency: 6.2%
References:2
Frequency: 6.2%
References:5
Frequency: 6.2%
References:1
Frequency: 6.2%
References:3
Frequency: 6.2%
References:6
Frequency: 6.2%
References:1
Frequency: 6.2%
References:1
Frequency: 6.2%
References:1
>2x increased risk for familial obesity
Frequency: 6.2%
References:1
Frequency: 6.2%
References:2
Frequency: 6.2%
References:2
Frequency: 6.2%
References:1
Frequency: 6.2%
References:2
Frequency: 6.2%
References:1
Frequency: 6.2%
References:2
Frequency: 6.2%
References:1
Frequency: 6.2%
References:1
average
Frequency: 6.2%
References:9
Frequency: 6.2%
References:2
?
Frequency: 6.2%
References:2
Frequency: 6.3%
References:1
Frequency: 6.4%
References:1
Frequency: 6.5%
References:3
increased risk for osteoporosis
Frequency: 7.1%
References:12
Frequency: 7.1%
References:1
Frequency: 7.1%
References:1
Frequency: 7.1%
References:3
Frequency: 7.1%
References:1
Frequency: 7.1%
References:1
Frequency: 7.1%
References:1
Frequency: 7.1%
References:1
Frequency: 7.1%
References:10
Frequency: 7.1%
References:1
Frequency: 7.1%
References:1
Frequency: 7.1%
References:3
Frequency: 7.1%
References:4
Frequency: 7.1%
References:5
Frequency: 7.1%
References:3
Frequency: 7.1%
References:4
Frequency: 7.1%
References:1
Frequency: 7.1%
References:3
Frequency: 7.1%
References:2
Frequency: 7.1%
References:1
Frequency: 7.1%
References:1
Frequency: 7.1%
References:1
Frequency: 7.1%
References:1
Frequency: 7.1%
References:1
Frequency: 7.1%
References:1
Frequency: 7.1%
References:1
Frequency: 7.1%
References:1
Frequency: 7.1%
References:1
Frequency: 7.1%
References:1
Frequency: 7.1%
References:13
Normal
Frequency: 7.1%
References:2
Frequency: 7.1%
References:3
Frequency: 7.2%
References:0
Frequency: 7.3%
References:1
Frequency: 7.3%
References:1
Frequency: 7.5%
References:0
Frequency: 7.7%
References:2
Frequency: 7.7%
References:109
increased risk of preeclampsia, also heart disease
Frequency: 7.7%
References:1
Frequency: 7.7%
References:56
Frequency: 7.7%
References:0
Frequency: 7.8%
References:1
Frequency: 7.8%
References:1
Frequency: 7.9%
References:1
Frequency: 8.0%
References:1
Frequency: 8.0%
References:1
Frequency: 8.0%
References:7
Frequency: 8.0%
References:1
Frequency: 8.0%
References:1
Frequency: 8.0%
References:1
Frequency: 8.0%
References:1
Frequency: 8.0%
References:1
Frequency: 8.0%
References:1
Frequency: 8.0%
References:1
Frequency: 8.0%
References:2
Frequency: 8.0%
References:2
Frequency: 8.0%
References:2
Frequency: 8.0%
References:0
Frequency: 8.0%
References:1
Frequency: 8.0%
References:3
Frequency: 8.0%
References:2
Frequency: 8.0%
References:2
Frequency: 8.0%
References:1
Frequency: 8.0%
References:4
Frequency: 8.0%
References:1
Frequency: 8.0%
References:1
Frequency: 8.0%
References:1
Frequency: 8.0%
References:2
Frequency: 8.0%
References:1
Frequency: 8.0%
References:1
Frequency: 8.0%
References:1
Frequency: 8.0%
References:1
Frequency: 8.0%
References:1
Frequency: 8.0%
References:1
Frequency: 8.0%
References:1
Frequency: 8.0%
References:2
Frequency: 8.1%
References:1
Frequency: 8.1%
References:14
Frequency: 8.1%
References:1
Frequency: 8.2%
References:19
Frequency: 8.8%
References:0
Frequency: 8.8%
References:6
Frequency: 8.8%
References:1
Frequency: 8.8%
References:0
Frequency: 8.8%
References:1
Frequency: 8.8%
References:1
Frequency: 8.8%
References:1
Frequency: 8.8%
References:0
Frequency: 8.8%
References:6
Frequency: 8.8%
References:1
Frequency: 8.8%
References:3
Frequency: 8.8%
References:0
Frequency: 8.8%
References:0
Frequency: 8.8%
References:0
Frequency: 8.8%
References:1
Frequency: 8.8%
References:2
Frequency: 8.8%
References:1
Frequency: 8.8%
References:1
Frequency: 8.8%
References:1
Frequency: 8.8%
References:1
Frequency: 8.8%
References:4
Frequency: 8.8%
References:1
Frequency: 8.8%
References:1
Frequency: 8.8%
References:1
Frequency: 8.8%
References:1
Frequency: 8.8%
References:1
Frequency: 8.8%
References:1
Frequency: 8.8%
References:8
Frequency: 8.8%
References:2
Frequency: 8.8%
References:10
Frequency: 8.8%
References:1
Frequency: 8.8%
References:0
Frequency: 8.8%
References:3
Frequency: 8.8%
References:4
Frequency: 8.8%
References:1
Frequency: 8.8%
References:2
None
Frequency: 8.8%
References:1
Frequency: 8.8%
References:1
Frequency: 8.8%
References:4
Frequency: 8.8%
References:1
Frequency: 8.8%
References:1
Frequency: 8.8%
References:1
Frequency: 8.8%
References:3
Frequency: 8.8%
References:2
Frequency: 8.9%
References:0
Frequency: 8.9%
References:0
Frequency: 8.9%
References:0
Frequency: 8.9%
References:1
Frequency: 8.9%
References:4
Frequency: 8.9%
References:1
Frequency: 8.9%
References:1
Frequency: 8.9%
References:1
Frequency: 8.9%
References:1
Frequency: 8.9%
References:2
Frequency: 8.9%
References:2
Frequency: 8.9%
References:0
Frequency: 9.0%
References:1
Frequency: 9.0%
References:1
Frequency: 9.0%
References:1
Frequency: 9.1%
References:2
Frequency: 9.2%
References:1
Frequency: 9.2%
References:8
Frequency: 9.2%
References:0
Frequency: 9.2%
References:1
Frequency: 9.2%
References:1
Frequency: 9.2%
References:1
Frequency: 9.2%
References:1
Frequency: 9.2%
References:2
Frequency: 9.4%
References:5
2.6x risk for priapism in SCA patients
Frequency: 9.4%
References:1
carrier of one CYP2C19 V331I allele
Frequency: 9.7%
References:1
Frequency: 9.7%
References:1
Frequency: 9.7%
References:1
Frequency: 9.7%
References:1
Frequency: 9.7%
References:1
Frequency: 9.7%
References:1
Frequency: 9.7%
References:1
Frequency: 9.7%
References:1
Frequency: 9.7%
References:3
Frequency: 9.7%
References:1
Frequency: 9.7%
References:2
Frequency: 9.7%
References:3
Frequency: 9.7%
References:1
Frequency: 9.7%
References:1
Frequency: 9.7%
References:1
Frequency: 9.7%
References:1
Frequency: 9.7%
References:1
Frequency: 9.7%
References:1
Frequency: 9.7%
References:1
Frequency: 9.7%
References:1
Frequency: 9.7%
References:2
Frequency: 9.7%
References:1
Frequency: 9.7%
References:12
Frequency: 9.7%
References:5
Frequency: 9.7%
References:1
Frequency: 9.7%
References:2
Frequency: 9.7%
References:49
Frequency: 9.7%
References:1
Frequency: 9.7%
References:1
Frequency: 9.7%
References:1
Frequency: 9.7%
References:1
Frequency: 9.7%
References:1
Frequency: 9.7%
References:2
Frequency: 9.7%
References:4
Frequency: 9.7%
References:2
Frequency: 9.7%
References:2
Frequency: 9.7%
References:7
Frequency: 9.7%
References:3
Frequency: 9.7%
References:1
Frequency: 9.7%
References:1
Frequency: 9.8%
References:1
Frequency: 9.8%
References:1
Frequency: 9.8%
References:1
Frequency: 9.8%
References:1
Frequency: 9.8%
References:1
Frequency: 9.8%
References:2
Frequency: 9.8%
References:3
Frequency: 9.9%
References:1
Frequency: 9.9%
References:1